Effect of Long-Term Aspirin Use on Embolic Events in Infective Endocarditis | Zendy

KwanLeung Chan | Zendy; James W. Tam | Zendy; Jean G. Dumesnil | Zendy; Bibiana Čujec | Zendy; Anthony J. Sanfilippo | Zendy; John Jue | Zendy; Michèle Turek | Zendy; Trevor I. Robinson | Zendy; Kona Williams | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Effect of Long-Term Aspirin Use on Embolic Events in Infective Endocarditis

Author(s) -

KwanLeung Chan,

James W. Tam,

Jean G. Dumesnil,

Bibiana Čujec,

Anthony J. Sanfilippo,

John Jue,

Michèle Turek,

Trevor I. Robinson,

Kona Williams

Publication year - 2007

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1086/524021

Subject(s) - aspirin , medicine , infective endocarditis , odds ratio , endocarditis , placebo , randomized controlled trial , embolism , surgery , pathology , alternative medicine

In a recent clinical trial, aspirin therapy was initiated approximately 34 days after the onset of symptoms but did not reduce the risk of embolism in patients with endocarditis. However, it is possible that aspirin used early in the course of the disease may be beneficial. The purpose of the study is to assess the effect of long-term daily aspirin use on the risk of embolic events in patients with infective endocarditis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research